Stay updated with breaking news from Replimune Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) insider Pamela Esposito sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $21.58, for a total transaction of $431,600.00. Following the completion of the transaction, the insider now directly owns 263,436 […]
Collectively referred to as the "Transaction"). The Transaction constituted a reverse takeover of the Company by FTP under applicable securities laws. FTP became a...
Replimune Group, Inc. (NASDAQ:REPL – Get Rating)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $23.48, but opened at $24.60. Replimune Group shares last traded at $24.39, with a volume of 44,521 shares. Wall Street Analysts Forecast Growth A number of research analysts have weighed in […]
Replimune Group (NASDAQ:REPL – Get Rating) had its target price upped by HC Wainwright from $50.00 to $51.00 in a research report sent to investors on Monday morning, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at […]
Replimune Group (NASDAQ:REPL – Get Rating) had its price target raised by HC Wainwright from $50.00 to $51.00 in a research report released on Monday, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at ($0.88) EPS, Q4 […]